Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.

15 Oct 2013

Scientists identify dangerous amount of methamphetamine analog in workout supplement Craze

An international team of scientists have identified potentially dangerous amounts of methamphetamine analog in the workout supplement Craze, a product widely sold across the U.S. and online.

15 Oct 2013

Genentech plans to invest over $285M for expansion of biologics manufacturing facilities

Genentech, a member of the Roche Group, today announced plans to invest more than $285 million for the expansion of its biologics manufacturing facilities in Vacaville and Oceanside, California.

14 Oct 2013

Novartis Inks Agreement For Immunogen's "TAP" ADC Technology

...

11 Oct 2013

Auxilium Licenses Stendra From Vivus For Up To $300M

...

11 Oct 2013

ImmunoGen signs new license agreement with Novartis

ImmunoGen, Inc., a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate technology, today announced that Novartis has licensed the exclusive right to use the Company's ADC technology to develop anticancer therapeutics to an undisclosed target.

11 Oct 2013

WHO prequalifies affordable vaccine to protect children against Japanese encephalitis

An affordable vaccine to protect children against deadly Japanese encephalitis has been prequalified by the World Health Organization, paving the way to reach millions more children across Asia at risk for the disease.

10 Oct 2013

Catalyst, Isu Abxis To Develop Hemophilia B Candidate

...

9 Oct 2013

AquaBased introduces new eco-friendly water-based adhesive for plastic-to-plastic bonding

AquaBased Technologies, a division of ADM Tronics Unlimited, Inc. (OTCQB:ADMT), has introduced AquaTack™ 7001-PAA, a new, eco-friendly, water-based adhesive specifically designed for use in flexographic presses and other roller coater applicators for the lamination of virtually any type of low surface energy plastic films as well as for other plastic-to-plastic bonding applications.

9 Oct 2013

X-spine launches three USFDA-cleared spinal implant systems

X-spine, a global leader in the design and manufacture of devices for the treatment of spinal disease, announces the market launch of three recently USFDA-cleared spinal implant systems. The systems are the IRIX-C cervical integrated interbody fusion system, the AXLE-X extended angle interspinous fixation system and the SILEX™ sacroiliac joint fusion system .

9 Oct 2013

Clinical Genomics Nabs Enterix, Aims To Launch New Bowel Cancer Blood Test

...

8 Oct 2013

Immutep, Eddingpharm partner to develop and commercialize ImmuFact IMP321

Immutep S.A., the biopharmaceutical company specializing in immuno-oncology, and Eddingpharm have entered into an agreement regarding the development, commercialization and manufacturing of Immutep’s ImmuFact IMP321.

7 Oct 2013

Kiadis Pharma signs Services Agreement with GRCBDS for Phase II clinical study with ATIR

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that a Services Agreement has been signed with the German Red Cross Blood Donor Service Baden-Wuerttemberg-Hessen (GRCBDS) whereby GRCBDS will provide pharmaceutical development and GMP manufacturing services for Kiadis Pharma's ongoing Phase II clinical study with ATIR™.

7 Oct 2013

MIT investigators receive DARPA grant to develop new technologies for BioMOD program

Investigators from MIT's Biomanufacturing Research Program (BioMAN) have received a $10.4 million grant from the Defense Advanced Research Projects Agency (DARPA) to develop new technologies for DARPA's Biologically-derived Medicines On Demand (BioMOD) program.

5 Oct 2013

FDA approves Discovery Lab’s updated product specifications for SURFAXIN lucinactant

Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the U.S. Food and Drug Administration (FDA) has agreed to the Company's updated product specifications for SURFAXIN® (lucinactant) Intratracheal Suspension which was approved for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.

5 Oct 2013

Study identifies new potential genetic culprits in origins of congenital heart defects

Mitochondria are the power plants of cells, manufacturing chemical fuel so a cell can perform its many tasks. These cellular power plants also are well known for their role in ridding the body of old or damaged cells.

5 Oct 2013

Cambridge Consultants helps MSF’s efforts to widen access to HIV viral load tests

Cambridge Consultants is working with Médecins Sans Frontières (MSF) to help support moves to expand access to vital diagnostic tests, which paves the way for better treatment of HIV in some of the world’s least-developed countries.

3 Oct 2013

Sun Pharma, Intrexon Team Up To Target Ocular Diseases

...

2 Oct 2013

Digital security: an interview with Jon Edgcombe, leader of the software technologies group at Cambridge Consultants

Digital security is a key requirement in our product designs, especially in markets such as healthcare where the design is complete long before final regulatory approval. From a commercial point of view, ignoring data privacy, device authentication, and anti-counterfeit at design stage is no longer a tenable position for a connected product that produces sensitive patient data – even if it is nominally pseudonomised.

2 Oct 2013

libragen contributes to success of PolyModE

libragen, a contract research organization dedicated to biocatalysis and metagenomics, has been a major contributor to the success of PolyModE (Polysaccharide Modifying Enzymes), a large collaborative research project funded by the European Community. The project, which began in 2009 and ended in April this year, looked at developing novel polysaccharide modifying enzymes for the optimized use of hydrocolloids as, for example, food additives or novel therapeutic agents in the food sciences and medical industries. Researchers focused on six industry-targeted hydrocolloids (alginates, carrageenans, chitosans, glycosaminoglycans, pectins, and xanthan gums) where traditional chemistry fails to achieve a certain desired modification.

2 Oct 2013

Manufacturing News and Research

Further Reading

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Scientists identify dangerous amount of methamphetamine analog in workout supplement Craze

Genentech plans to invest over $285M for expansion of biologics manufacturing facilities

Novartis Inks Agreement For Immunogen's "TAP" ADC Technology

Auxilium Licenses Stendra From Vivus For Up To $300M

ImmunoGen signs new license agreement with Novartis

WHO prequalifies affordable vaccine to protect children against Japanese encephalitis

Catalyst, Isu Abxis To Develop Hemophilia B Candidate

AquaBased introduces new eco-friendly water-based adhesive for plastic-to-plastic bonding

X-spine launches three USFDA-cleared spinal implant systems

Clinical Genomics Nabs Enterix, Aims To Launch New Bowel Cancer Blood Test

Immutep, Eddingpharm partner to develop and commercialize ImmuFact IMP321

Kiadis Pharma signs Services Agreement with GRCBDS for Phase II clinical study with ATIR

MIT investigators receive DARPA grant to develop new technologies for BioMOD program

FDA approves Discovery Lab’s updated product specifications for SURFAXIN lucinactant

Study identifies new potential genetic culprits in origins of congenital heart defects

Cambridge Consultants helps MSF’s efforts to widen access to HIV viral load tests

Sun Pharma, Intrexon Team Up To Target Ocular Diseases

Digital security: an interview with Jon Edgcombe, leader of the software technologies group at Cambridge Consultants

libragen contributes to success of PolyModE

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy